Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06053385 · ClinicalTrials.gov registry record · NA
Impact of Commercial "Sleep Lotion" on Salivary Melatonin Levels and Sleep Quality in Undergraduates
A NA study, sponsored by University of Redlands.
- Completed
- Registry status
- NA
- Development phase
- 63
- Enrollment target
NCT06053385: Completed NA study, sponsored by University of Redlands.
NCT06053385 is a NA study that has completed, run by University of Redlands. The registered enrollment target is 63 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06053385, a NA study, has completed, sponsored by University of Redlands.
- COMPLETED
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to test an over-the-counter "sleep lotion" in healthy undergraduate college students. The main questions it aims to answer are: * Does an over-the-counter "sleep lotion" containing melatonin actually increase melatonin levels in participants compared to a placebo (control) lotion? * Does an over-the-counter "sleep lotion" containing melatonin improve the quality of participants' sleep compared to a placebo (control) lotion? Participants will: * provide three saliva samples on each of two nights * apply melatonin-containing "sleep lotion" on one night and a placebo (control with no melatonin) lotion on the other night * answer questionnaires about gender, race, ethnicity, medication use, exercise, and sleep quality
Primary Outcome
pg/ml of melatonin in saliva measured by enzyme-linked immunosorbent assay
Interventions
- OTHER Melatonin sleep lotion
- OTHER Placebo control lotion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2022-02-09 |
| Est. Completion | 2023-04-20 |
| Phase | NA |
What the finished NCT06053385 record still lists
NCT06053385 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 63 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Melatonin sleep lotion is the first listed.
NCT06053385 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06053385 about?
NCT06053385 is a clinical study titled "Impact of Commercial "Sleep Lotion" on Salivary Melatonin Levels and Sleep Quality in Undergraduates". The goal of this clinical trial is to test an over-the-counter "sleep lotion" in healthy undergraduate college students. The main questions it aims to answer are: * Does an over-the-counter "sleep lotion" containing melatonin actually increase melatonin levels in participants compared to a placebo ...
What is the current status of trial NCT06053385?
This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2022-02-09. Estimated completion is 2023-04-20.
What interventions are being tested in trial NCT06053385?
The interventions under investigation include: Melatonin sleep lotion (OTHER), Placebo control lotion (OTHER).
Who is sponsoring clinical trial NCT06053385?
This trial is sponsored by University of Redlands, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06053385's enrollment target sits among peer trials
63 1157th of 2000 higher than 844 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03383575 · 63 participants · Phase 2
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- NCT04870944 · 63 participants · Phase 1
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- NCT05031897 · 63 participants · Phase 2
Two Step Haplo With Radiation Conditioning
- NCT05312671 · 63 participants · Phase 2
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI